Brief: Gritstone Bio And Genevant Sciences Announce Option And License Agreement
15/08/2023 12:33
Gritstone bio Inc GRTS.O :
* GRITSTONE BIO AND GENEVANT SCIENCES ANNOUNCE OPTION AND
LICENSE
AGREEMENT
* GRITSTONE BIO: GENEVANT IS ELIGIBLE TO RECEIVE FROM CO
OPTION
MAINTENANCE,EXERCISE FEES UP TO $136 MILLION IN CONTINGENT
MILESTONE PAYMENTS PER PRODUCT
Source text for Eikon: ID:nGNXPnl7c
Further company coverage: GRTS.O
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy